Table 2. Demographic characteristics and clinical features of patients in the study population


  Complementary Medicine  
 
 
  Not Used
n (%)
Used
n(%)
p

Total 707 (81.1) 165 (18.9)  

Age (mean±sd) 55.5±13.2 54.2±12.4 0.272
Gender     0.778
Female 382 (54.0) 87 (52.8)  
Male 305 (43.1) 73 (44.2)  
Unknown 20 (2.9) 5 (3.0)  
Education Level     0.119
Primary school 378 (53.5) 81 (49.1)  
High school 141 (19.9) 32 (19.4)  
University 120(17.0) 38 (23.0)  
Illiterate 51(7.2) 6 (3.6)  
Unknown 17(2.4) 8 (4.8)  
Working status     0.355
Works 129 (18.2) 37 (22.4)  
Unemployed 56 (7.9) 7 (4.2)  
Retired 254 (35.9) 57 (34.5)  
Student 9 (1.3) 1 (0.6)  
Housewife 252 (35.6) 61 (37.0)  
Unknown 7 (1.0) 2 (1.2)  
Place of residence     0.187
Metropolis 450 (63.6) 106 (64.2)  
City 61 (8.6) 7 (4.2)  
Town 141 (19.9) 41 (24.8)  
Village 47(6.6) 11 (6.7)  
Unknown 8 (1.1) -  
Income (TL/month)     0.310
≤1000 353 (49.9) 76 (46.1)  
1001-4000 284 (40.2) 78 (47.3)  
>4000 37(5.3) 5 (3.0)  
Unknown 32 (4.6) 6 (3.6)  
Stage     0.001
Locally advanced 346 (48.9) 59 (35.8)  
Metastatic 269 (38.1) 88 (53.3)  
Unknown 92 (13.0) 18 (10.9)  
Treatment Status     0.185
Active 530 (75.0) 133 (80.6)  
Completed 146 (20.7) 27 (16.4)  
Unknown 31 (4.3) 5 (3.0)  
Time since diagnosis(months)      0.080
≤12 327 (46.2) 60 (36.4)  
13-36 177 (25.0) 44 (26.6)  
>36 175 (24.8) 51 (30.9)  
Unknown 28 (4.0) 10 (6.1)  

TL: Turkish Lira (1TL= 1.8 US dollar= 2.3 Euro); sd: standard deviation.

Turhal Serdar et al.Journal of Cancer Therapeutics and Research  2012 1:33DOI : 10.7243/2049-7962-1-33